DURECT Corp DRRX:NASDAQ

RT Quote | NASDAQ | USD
Last | 05/24/22 EDT
0.3992quote price arrow up+0.0092 (+2.36%)
Volume
827,423
52 week range
0.36 - 1.84
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.3992
  • 52 Week High1.84
  • 52 Week High Date06/09/21
  • 52 Week Low0.36
  • 52 Week Low Date05/24/22

Key Stats

  • Market Cap90.92M
  • Shares Out227.76M
  • 10 Day Average Volume0.91M
  • Dividend-
  • Dividend Yield-
  • Beta1.48
  • YTD % Change-59.51

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.3992
  • 52 Week High1.84
  • 52 Week High Date06/09/21
  • 52 Week Low0.36
  • 52 Week Low Date05/24/22
  • Market Cap90.92M
  • Shares Out227.76M
  • 10 Day Average Volume0.91M
  • Dividend-
  • Dividend Yield-
  • Beta1.48
  • YTD % Change-59.51

RATIOS/PROFITABILITY

  • EPS (TTM)-0.16
  • P/E (TTM)-2.46
  • Fwd P/E (NTM)-2.03
  • EBITDA (TTM)-34.857M
  • ROE (TTM)-57.18%
  • Revenue (TTM)13.68M
  • Gross Margin (TTM)85.83%
  • Net Margin (TTM)-270.27%
  • Debt To Equity (MRQ)43.62%

EVENTS

  • Earnings Date07/27/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On DURECT Corp

There is no recent news for this security.

Profile

MORE
DURECT Corporation is a biopharmaceutical company that is focused on advancing lifesaving investigational therapies. The Company's product candidates include DUR-928 oral for metabolic/lipid disorders, and DUR-928, injectable for acute organ injuries. The Company’s other commercial product candidates include POSIMIR, PERSERIS and Methydur Sustained Release Capsules. The Company is conducting a Phase IIb study (AHFIRM) of larsucosterol (DUR-928) in subjects with severe...
David Hoffmann
Independent Chairman of the Board
James Brown
President, Chief Executive Officer, Director
Jian Li
Interim Principal Accounting Officer
Address
10260 Bubb Rd
Cupertino, CA
95014-4166
United States

Top Peers

SYMBOLLASTCHG%CHG
ETON
Eton Pharmaceuticals Inc
3.20-0.06-1.84%
PLXP
PLx Pharma Inc
2.44-0.22-8.27%
GTBP
GT Biopharma Inc
2.60-0.01-0.38%
ADMP
Adamis Pharmaceuticals Corp
0.4064-0.0005-0.1229%
MDWD
Mediwound Ltd
1.73-0.10-5.46%